CSIMarket
 


Imara inc   (IMRA)
Other Ticker:  
 

Cumulative Imara Inc 's Working Capital Ratio for Trailing Twelve Months Period

IMRA's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

IMRA Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth -89.33 % -52.65 % 31.26 % 265.8 % 281.12 %
Y / Y Current Assets Growth -44.24 % -9.95 % -2.28 % 2.53 % 6.3 %
Working Capital Ratio for Trailing Twelve Months Period 15.92 13.7 12.19 13.04 16.09
Total Ranking # 223 # 373 # 464 # 453 # 341
Seq. Current Liabilities Growth -76.77 % -54.28 % 0.18 % 0.31 % 3.08 %
Seq. Current Assets Growth -8.02 % -18.17 % -15.28 % -12.55 % 48.54 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Current Liabilities decreased faster than Imara Inc 's average Current Assets, this led to increase in in Imara Inc 's Working Capital Ratio for Trailing Twelve Months Period to 15.92, Working Capital Ratio for Trailing Twelve Months Period remained below Imara inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 83 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Imara Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 223, from total ranking in previous quarter at 373.

What is Working Capital Ratio?
More about IMRA
Working Capital Ratio IMRA in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 84
Sector # 131
S&P 500 # 223


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
19.22 14.78 12.19
(Dec 31 2020)   (Mar 31 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Annovis Bio inc   43.66 
Anebulo Pharmaceuticals Inc  40.07 
Xenon Pharmaceuticals Inc   40.02 
Terns Pharmaceuticals Inc   39.39 
Zomedica Corp   38.29 
Infinity Pharmaceuticals Inc   35.89 
Artelo Biosciences Inc   35.70 
Theseus Pharmaceuticals inc   34.95 
Cocrystal Pharma Inc.  33.88 
Nextcure Inc   32.81 
Stoke Therapeutics Inc   32.10 
Eqrx Inc   31.83 
Rezolute Inc   30.44 
Nanoviricides inc   30.30 
Day One Biopharmaceuticals Inc   30.05 
Immix Biopharma Inc   29.94 
Synaptogenix Inc   28.93 
Xortx Therapeutics Inc   28.78 
Nuvalent Inc   28.46 
Kezar Life Sciences Inc   28.23 
Diamedica Therapeutics Inc   28.02 
Edgewise Therapeutics inc.  26.97 
Merrimack Pharmaceuticals Inc  26.97 
Spruce Biosciences Inc   26.94 
Janux Therapeutics Inc   26.91 
Karuna Therapeutics Inc   26.74 
Pmv Pharmaceuticals Inc   26.51 
Immuneering Corp  26.41 
Gemini Therapeutics Inc   26.21 
Dice Therapeutics Inc   25.72 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

REFR's Profile

Stock Price

REFR's Financials

Business Description

Fundamentals

Charts & Quotes

REFR's News

Suppliers

REFR's Competitors

Customers & Markets

Economic Indicators

REFR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071